Personalising whole genome sequencing doubles diagnosis of rare diseasesÂ
Drug Discovery World
NOVEMBER 7, 2022
They subsequently applied additional bioinformatic approaches, using advanced computer technologies to identify genetic alterations in a patients’ DNA which may be causing disease but had been overlooked during routine testing. . It can also permit targeted screening of known disease complications and access to drug studies.
52 
Let's personalize your content